Changes in the Microbiome in Cirrhosis and Relationship to Complications: Hepatic Encephalopathy, Spontaneous Bacterial Peritonitis, and Sepsis

Seminars in Liver Disease

Volumn 36, Issue 4, 2016, Pages 327-330

  Lachar, Jatinder ^a   Bajaj, Jasmohan S ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

cirrhosis dysbiosis ratio; hepatic encephalopathy; infection; lactulose; rifaximin

Indexed keywords

BILE ACID; PROTON PUMP INHIBITOR;

ARTICLE; BACTERIAL PERITONITIS; DECOMPENSATED LIVER CIRRHOSIS; DISEASE ASSOCIATION; DYSBIOSIS; HEPATIC ENCEPHALOPATHY; HUMAN; INTESTINE FLORA; LIVER CIRRHOSIS; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SEPSIS; ANIMAL; BACTERIAL TRANSLOCATION; COMPLICATION; IMMUNOLOGY; LIVER; MICROBIOLOGY; PERITONITIS;

ANIMALS; BACTERIAL TRANSLOCATION; GASTROINTESTINAL MICROBIOME; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER; LIVER CIRRHOSIS; PERITONITIS; PROTON PUMP INHIBITORS; SEPSIS;

EID: 85006858044     PISSN: 02728087     EISSN: 10988971     Source Type: Journal    
DOI: 10.1055/s-0036-1593881     Document Type: Article

References (29)

1. Peery A. F., Crockett S. D., Barritt A. S., et al. Burden of gastrointestinal, liver, and pancreatic diseases in the United States. Gastroenterology: 2015; 149 7 1731 1741.e3
2. Schnabl B., Brenner D. A. Interactions between the intestinal microbiome and liver diseases. Gastroenterology: 2014; 146 6 1513 1524
3. Khanna S., Tosh P. K. A clinician's primer on the role of the microbiome in human health and disease. Mayo Clin Proc: 2014; 89 1 107 114
4. Karlsson F., Tremaroli V., Nielsen J., Bäckhed F. Assessing the human gut microbiota in metabolic diseases. Diabetes: 2013; 62 10 3341 3349
5. Bajaj J. S. The role of microbiota in hepatic encephalopathy. Gut Microbes: 2014; 5 3 397 403
6. Ridlon J. M., Alves J. M., Hylemon P. B., Bajaj J. S. Cirrhosis, bile acids and gut microbiota: unraveling a complex relationship. Gut Microbes: 2013; 4 5 382 387
7. Kakiyama G., Pandak W. M., Gillevet P. M., et al. Modulation of the fecal bile acid profile by gut microbiota in cirrhosis. J Hepatol: 2013; 58 5 949 955
8. Liu Q., Duan Z. P., Ha D. K., Bengmark S., Kurtovic J., Riordan S. M. Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology: 2004; 39 5 1441 1449
9. Gómez-Hurtado I., Such J., Sanz Y., Francés R. Gut microbiota-related complications in cirrhosis. World J Gastroenterol: 2014; 20 42 15624 15631
10. Shawcross D., Jalan R. The pathophysiologic basis of hepatic encephalopathy: central role for ammonia and inflammation. Cell Mol Life Sci: 2005; 62 19-20 2295 2304
11. Bajaj J. S., Hylemon P. B., Ridlon J. M., et al. Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation. Am J Physiol Gastrointest Liver Physiol: 2012; 303 6 G675 G685
12. Bajaj J. S., Betrapally N. S., Gillevet P. M. Decompensated cirrhosis and microbiome interpretation. Nature: 2015; 525 7569 E1 E2
13. Bajaj J. S., Betrapally N. S., Hylemon P. B., et al. Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy. Hepatology: 2015; 62 4 1260 1271
14. Santiago A., Pozuelo M., Poca M., et al. Alteration of the serum microbiome composition in cirrhotic patients with ascites. Sci Rep: 2016; 6 25001
15. Vilstrup H., Amodio P., Bajaj J., et al. Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology: 2014; 60 2 715 735
16. Bajaj J. S., Saeian K., Schubert C. M., et al. Minimal hepatic encephalopathy is associated with motor vehicle crashes: the reality beyond the driving test. Hepatology: 2009; 50 4 1175 1183
17. Patidar K. R., Thacker L. R., Wade J. B., et al. Covert hepatic encephalopathy is independently associated with poor survival and increased risk of hospitalization. Am J Gastroenterol: 2014; 109 11 1757 1763
18. Riordan S. M., Williams R. Gut flora and hepatic encephalopathy in patients with cirrhosis. N Engl J Med: 2010; 362 12 1140 1142
19. Rai R., Saraswat V. A., Dhiman R. K. Gut microbiota: its role in hepatic encephalopathy. J Clin Exp Hepatol: 2015; 5 01 S29 S36
20. Kang D. J., Betrapally N. S., Ghosh S. A., et al. Gut microbiota drive the development of neuroinflammatory response in cirrhosis in mice. Hepatology: 2016; 64 4 1232 1248
21. Ahluwalia V., Betrapally N. S., Hylemon P. B., et al. Impaired gut-liver-brain axis in patients with cirrhosis. Sci Rep: 2016; 6 26800
22. Bajaj J. S., Heuman D. M., Hylemon P. B., et al. Altered profile of human gut microbiome is associated with cirrhosis and its complications. J Hepatol: 2014; 60 5 940 947
23. Wiest R., Lawson M., Geuking M. Pathological bacterial translocation in liver cirrhosis. J Hepatol: 2014; 60 1 197 209
24. Tuomisto S., Pessi T., Collin P., Vuento R., Aittoniemi J., Karhunen P. J. Changes in gut bacterial populations and their translocation into liver and ascites in alcoholic liver cirrhotics. BMC Gastroenterol: 2014; 14 40 230X
25. Kakiyama G., Hylemon P. B., Zhou H., et al. Colonic inflammation and secondary bile acids in alcoholic cirrhosis. Am J Physiol Gastrointest Liver Physiol: 2014; 306 11 G929 G937
26. Bajaj J. S., Cox I. J., Betrapally N. S., et al. Systems biology analysis of omeprazole therapy in cirrhosis demonstrates significant shifts in gut microbiota composition and function. Am J Physiol Gastrointest Liver Physiol: 2014; 307 10 G951 G957
27. Freedberg D. E., Lebwohl B., Abrams J. A. The impact of proton pump inhibitors on the human gastrointestinal microbiome. Clin Lab Med: 2014; 34 4 771 785
28. Chen Y., Guo J., Qian G., et al. Gut dysbiosis in acute-on-chronic liver failure and its predictive value for mortality. J Gastroenterol Hepatol: 2015; 30 9 1429 1437
29. Bajaj J. S., Betrapally N. S., Hylemon P. B., et al. Gut microbiota alterations can predict hospitalizations in cirrhosis independent of diabetes mellitus. Sci Rep: 2015; 5 18559